dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell
NCT ID: NCT02430376
Last Updated: 2019-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3280 participants
OBSERVATIONAL
2015-04-25
2016-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Pentalogy of Cantrell (POC) is a syndrome that involves many heart abnormalities as well as large defects in the chest and abdominal wall. This often results in the heart and other organs being present outside the body at birth. Surgeons have learned to replace them and repair the heart. Researchers want to find possible gene changes that cause POC. To do this, they want to study data from the Pediatric Cardiovascular Genetics Consortium (PCGC) Cohort. The PCGC collects data and DNA samples from people with heart diseases and their families
Objectives:
\- To find gene mutations in people with Pentalogy of Cantrell (POC) or other related syndromes.
Eligibility:
\- PCGC data and DNA samples that are open to study by the public.
Design:
* Researchers will study the data from the PCGC.
* The gene testing being done in this study was consented to in the original studies. No new consent or waiver request is required.
* The study will last 1 year.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC)
NCT03347214
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
NCT02432079
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
NCT01196182
Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny
NCT01460316
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
NCT00243776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert S Adelstein, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Heart, Lung, and Blood Institute (NHLBI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-H-N111
Identifier Type: -
Identifier Source: secondary_id
999915111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.